HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$6.04
Day range
$5.70 - $5.96
Year range
$3.81 - $10.08
Market cap
1.00B USD
Avg Volume
1.91M
P/E ratio
1,809.97
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 85.81M | 42.78% |
Operating expense | 58.09M | 18.69% |
Net income | 11.08M | 316.72% |
Net profit margin | 12.91 | 251.70% |
Earnings per share | 0.06 | 300.00% |
EBITDA | 19.82M | 321.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 111.04M | 55.04% |
Total assets | 383.53M | 18.72% |
Total liabilities | 369.84M | 4.87% |
Total equity | 13.69M | — |
Shares outstanding | 172.43M | — |
Price to book | 75.50 | — |
Return on assets | 11.13% | — |
Return on capital | 15.87% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 11.08M | 316.72% |
Cash from operations | 20.04M | 914.84% |
Cash from investing | -333.00K | -103.32% |
Cash from financing | -266.00K | -166.83% |
Net change in cash | 19.44M | 56.95% |
Free cash flow | 11.50M | 11.96% |
About
Founded
2005
Headquarters
Website
Employees
435
